Poulin Y - Search Results

1

Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up.

Langley RG, Lebwohl M, Krueger GG, Szapary PO, Wasfi Y, Chan D, Hsu MC, You Y, Poulin Y, Korman N, Prinz JC, Reich K; PHOENIX 2 Investigators. Langley RG, et al. Among authors: poulin y. Br J Dermatol. 2015;172(5):1371-83. doi: 10.1111/bjd.13469. Epub 2015 Mar 22. Br J Dermatol. 2015. PMID: 25307931 Free article. Clinical Trial.

2

Tazarotene in combination with topical corticosteroids.

Lebwohl M, Poulin Y. Lebwohl M, et al. Among authors: poulin y. J Am Acad Dermatol. 1998 Oct;39(4 Pt 2):S139-43. doi: 10.1016/s0190-9622(98)70311-1. J Am Acad Dermatol. 1998. PMID: 9777792 Review.

3

Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel.

Rivers JK, Arlette J, Shear N, Guenther L, Carey W, Poulin Y. Rivers JK, et al. Among authors: poulin y. Br J Dermatol. 2002 Jan;146(1):94-100. doi: 10.1046/j.1365-2133.2002.04561.x. Br J Dermatol. 2002. PMID: 11841372 Clinical Trial.

4

The use of alefacept in the treatment of psoriasis.

Langley R, Gupta AK, Poulin Y, Guenther L, Barber K, Gulliver W, Lynde C. Langley R, et al. Among authors: poulin y. J Cutan Med Surg. 2004 Aug;8 Suppl:14-8. doi: 10.1007/s10227-004-2004-5. J Cutan Med Surg. 2004. PMID: 15655585 Review. No abstract available.

5

Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004.

Guenther L, Langley RG, Shear NH, Bissonnette R, Ho V, Lynde C, Murray E, Papp K, Poulin Y, Zip C. Guenther L, et al. Among authors: poulin y. J Cutan Med Surg. 2004 Sep-Oct;8(5):321-37. doi: 10.1007/s10227-005-0035-1. J Cutan Med Surg. 2004. PMID: 15868311

6

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis.

Papp KA, Ho V, Langley R, Lynde C, Poulin Y, Shear N, Toole J, Zip C. Papp KA, et al. Among authors: poulin y. J Cutan Med Surg. 2006;9 Suppl 1:26-32. doi: 10.1007/s10227-006-0104-0. J Cutan Med Surg. 2006. PMID: 16633859 Review.

7

Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches.

Langley RG, Ho V, Lynde C, Papp KA, Poulin Y, Shear N, Toole J, Zip C. Langley RG, et al. Among authors: poulin y. J Cutan Med Surg. 2006;9 Suppl 1:18-25. doi: 10.1007/s10227-006-0103-1. J Cutan Med Surg. 2006. PMID: 16633860 Review.

8

Safety and efficacy of a milk-derived extract in the treatment of plaque psoriasis: an open-label study.

Poulin Y, Pouliot Y, Lamiot E, Aattouri N, Gauthier SF. Poulin Y, et al. J Cutan Med Surg. 2005 Dec;9(6):271-5. doi: 10.1007/s10227-005-0103-6. J Cutan Med Surg. 2005. PMID: 16699908 Clinical Trial.

9

XP-828l in the treatment of mild to moderate psoriasis: randomized, double-blind, placebo-controlled study.

Poulin Y, Bissonnette R, Juneau C, Cantin K, Drouin R, Poubelle PE. Poulin Y, et al. J Cutan Med Surg. 2006 Sep-Oct;10(5):241-8. doi: 10.2310/7750.2006.00049. J Cutan Med Surg. 2006. PMID: 17234108 Clinical Trial.

10

Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.

Tyring S, Gordon KB, Poulin Y, Langley RG, Gottlieb AB, Dunn M, Jahreis A. Tyring S, et al. Among authors: poulin y. Arch Dermatol. 2007 Jun;143(6):719-26. doi: 10.1001/archderm.143.6.719. Arch Dermatol. 2007. PMID: 17576937 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters